Samsung Medical Center
| Republik Korea | Türkei | Österreich | |
| Knochenmarktransplantation | von $55,000 | von $36,000 | von $140,000 |
| Chemotherapie bei Brustkrebs | von $19,200 | von $1,200 | von $15,000 |
| Autologe Knochenmarktransplantation | von $42,000 | von $31,500 | von $50,000 |
| Allogene Knochenmarktransplantation von einem verwandten Spender | von $75,000 | von $65,000 | von $150,000 |
| Allogene Knochenmarktransplantation von einem nicht verwandten Spender | von $145,000 | von $80,000 | von $180,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Follikuläres Lymphom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Follikuläres Lymphom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Follikuläres Lymphom-Behandlungsreise nie allein.
Top-tier centers for follicular lymphoma in the Republic of Korea include Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital. These JCI-accredited facilities provide multidisciplinary care. They utilize advanced PET-CT imaging and bone marrow analysis. Specialized teams manage complex B-cell malignancies.
Bookimed Expert Insight: While many choose hospitals by general reputation, the patient volume data reveals a clear quality signal. Asan Medical Center and Severance Hospital each handle over 180,000 to 4,000,000 patients annually. This massive scale ensures hematology teams see rare follicular lymphoma variations daily. This volume leads to superior diagnostic accuracy in pathology re-reads.
Patient Consensus: Patients emphasize getting a second opinion at a major Seoul-based university hospital before starting therapy. They note that having pathology results re-evaluated by specialized hematologic teams often refines the treatment plan.
South Korean clinics prioritize rituximab-based immunotherapy for advanced follicular lymphoma. Treatment is highly customized by disease stage. Localized cases often undergo targeted radiation. Advanced, asymptomatic patients may require only observation. Leading Seoul-based centers maintain high overall survival rates through integrated hemato-oncology units.
Bookimed Expert Insight: While many countries use R-CHOP chemotherapy, Korean academic centers like Samsung Medical Center and Asan Medical Center increasingly prefer the Bendamustine-Rituximab combination. This preference stems from providing lower toxicity than R-CHOP. These major facilities manage massive patient volumes, with Samsung alone treating over 2,000,000 patients annually across all departments.
Patient Consensus: Patients note that doctors often recommend watchful waiting for slow-growing, asymptomatic lymphoma. Many express initial anxiety about this `doing nothing` approach, but later appreciate avoiding intensive therapy when unnecessary.
South Korea offers innovative follicular lymphoma treatments including bispecific antibodies like Lunsumio and CAR T-cell therapies. JCI-accredited centers in Seoul utilize these for relapsed cases. Patients access advanced protocols via fast-track programs and clinical trials at specialized oncology facilities with presidential-level standards.
Bookimed Expert Insight: Seoul hospitals like Samsung Medical Center and Asan Medical Center manage massive patient volumes. Samsung alone handles over 2 million patients yearly. This high frequency creates deep expertise in managing complex immunotherapy side effects. Patients often find the most stable access to fast-tracked drugs like epcoritamab at these high-volume tertiary centers.
Patient Consensus: Patients note that major university hospitals in Seoul provide the most reliable access to modern rituximab-based therapies. Many emphasize that joining a clinical trial is often the most practical way to receive the latest targeted treatments.
Korean medical teams ensure clear communication through International Healthcare Centers and dedicated medical coordinators. They use specialized translators to bridge language gaps during consultations. Many oncologists at institutions like Asan Medical Center train abroad and speak English. Digital systems also provide translated medical reports and instructions.
Bookimed Expert Insight: Clear communication in Korea depends on the hospital's digital infrastructure. Seoul National University Hospital has been fully digitalized since 2004. This allows coordinators to access your real-time data faster. Modern systems ensure your English medical records are updated instantly across all departments. This prevents critical details from being lost during staff handovers.
Patient Consensus: Patients note that preparing a typed list of symptoms helps coordinators translate more accurately. They emphasize that while doctors speak English, having an assigned coordinator is vital when talking to nurses or lab staff.
Newly arriving follicular lymphoma patients in South Korea undergo a standardized 14-day pathway at JCI-accredited tertiary centers. The process includes excisional biopsy for grading, PET-CT staging, and tumor burden assessment using GELF criteria. Treatment involves rituximab-based immunochemotherapy or observation according to international protocols.
Bookimed Expert Insight: Clinical volume at major Seoul-based facilities mirrors their quality. Asan Medical Center manages over 10,000 outpatients daily. This massive throughput allows Korean oncologists to specialize deeply. Many specialists focus exclusively on specific lymphoma subtypes. This leads to high precision in pathology reviews.
Patient Consensus: Patients note that a diagnosis does not always mean immediate treatment. Expect a re-review of original pathology slides before starting any protocol.